Medical X-Ray Fluoroscopy System for ERCP Market Size, Share, Growth, and Industry Analysis, By Type ( Fixed X-ray Fluoroscopy System, Mobile X-ray Fluoroscopy System), By Application (Public Hospital, Private Hospital), Regional Insights and Forecast From 2026 To 2035

Medical X-Ray Fluoroscopy System for ERCP Market Overview

The global medical x-ray fluoroscopy system for ercp market size is projected at USD 1067.65 Million in 2026 and is expected to hit USD 1788.54 Million by 2035 with a CAGR of 5.9% during the forecast from 2026 to 2035.

The medical x-ray fluoroscopy system for ERCP market comprises specialized imaging equipment used to provide real-time visualization during endoscopic retrograde cholangiopancreatography procedures. These systems support guidewire positioning, contrast visualization, stone extraction, sphincterotomy, biopsy, and stent placement within the biliary and pancreatic ducts. Fixed x-ray fluoroscopy systems accounted for approximately 65% of the market in 2024, reflecting their importance in dedicated endoscopy and interventional suites. ERCP procedures commonly require fluoroscopic exposure for several minutes, while therapeutic interventions can require substantially longer imaging. Demand is therefore centered on systems offering high-resolution imaging, precise positioning, pulsed fluoroscopy, dose management, ergonomic operation, and efficient integration with endoscopy workflows.

The United States represents a leading market for medical x-ray fluoroscopy systems for ERCP because of advanced gastroenterology infrastructure, high availability of therapeutic endoscopy, established hospital networks, and rapid adoption of digital imaging technologies. U.S. hospitals increasingly prioritize fluoroscopy platforms that combine high-quality dynamic imaging with dose-management capabilities and efficient room utilization. The market is supported by strong demand from tertiary hospitals, academic medical centers, private healthcare groups, and specialized gastrointestinal facilities. Advanced flat-panel detectors, automated positioning, pulsed fluoroscopy, digital image storage, and dose monitoring are becoming increasingly important purchasing criteria. Replacement of older fluoroscopy equipment also creates opportunities as healthcare providers modernize endoscopy suites.

Key Findings

•        By Type: Fixed X-ray Fluoroscopy Systems lead market share, while Mobile X-ray Fluoroscopy Systems represent the fastest-growing segment at 5.9% CAGR.

•        By Application: Public Hospitals lead application share, while Private Hospitals expand steadily, supported by specialized ERCP services, modernization, and 5.9% CAGR.

•        By Geography: North America holds largest regional share, while Asia represents fastest-growing region, supported by expanding healthcare infrastructure and 5.9% CAGR.

Medical X-Ray Fluoroscopy System for ERCP Market Latest Trends

The medical x-ray fluoroscopy system for ERCP market is increasingly influenced by demand for sharper real-time imaging, lower radiation exposure, automated workflow support, and improved procedural ergonomics. ERCP depends on fluoroscopy to confirm catheter and guidewire positioning, visualize biliary and pancreatic anatomy, and support therapeutic interventions. Clinical guidance indicates that fluoroscopy time during ERCP is commonly several minutes, with therapeutic procedures generally requiring longer exposure. Consequently, manufacturers are prioritizing pulsed fluoroscopy, dose monitoring, advanced image processing, and optimized detector performance.

Fixed fluoroscopy systems continue to dominate because dedicated ERCP suites require stable imaging geometry, broad patient access, large detector coverage, and integration with endoscopy equipment. Mobile systems are gaining attention where hospitals need flexible imaging capacity, particularly in smaller facilities and procedure rooms with changing clinical requirements. Flat-panel detector technology is replacing older image intensifier configurations because it can provide digital images with improved workflow integration and efficient image storage.

Artificial intelligence is becoming an important development area. Intelligent workflow tools can assist positioning, protocol selection, image optimization, and dose management. Siemens Healthineers introduced the Luminos Q.namix platform with automated workflow support, touch-based controls, and low-dose imaging capabilities, while Canon Medical introduced the Adora DRFi hybrid radiography and fluoroscopy system in the United States in March 2025. Shimadzu also expanded its mobile fluoroscopy portfolio with the SC15 and OPESCOPE ACTENO FD15 in April 2026. These developments demonstrate the market's movement toward multifunctional, digitally integrated imaging platforms.

Medical X-Ray Fluoroscopy System for ERCP Market Dynamics

DRIVER

"Rising demand for minimally invasive diagnosis and treatment of biliary and pancreatic disorders."

The increasing use of minimally invasive gastrointestinal interventions is a central driver for the medical x-ray fluoroscopy system for ERCP market. ERCP is used for therapeutic management of bile duct stones, strictures, obstruction, leaks, selected pancreatic disorders, and other biliary conditions. Fluoroscopy provides real-time visualization that enables clinicians to guide catheters, guidewires, contrast material, dilation devices, extraction balloons, and stents through complex anatomical structures.

The growing preference for minimally invasive treatment can reduce the need for more invasive surgical approaches in suitable patients. Hospitals therefore require imaging platforms capable of supporting increasingly complex therapeutic procedures. Advanced fluoroscopy systems provide high-resolution dynamic images while allowing clinicians to control imaging parameters during the intervention.

The market also benefits from aging populations and increasing prevalence of gastrointestinal disorders. Hospitals with established gastroenterology departments are upgrading older fluoroscopy systems with digital flat-panel detectors, automated positioning, pulsed imaging, and dose-management software. Around 65% of the market is represented by fixed fluoroscopy systems, highlighting the importance of dedicated procedure-room infrastructure. The combination of rising therapeutic procedure demand, equipment replacement, and technology modernization is strengthening procurement activity.

RESTRAINT

"Radiation exposure concerns and high equipment acquisition costs."

Radiation exposure remains a major restraint because ERCP fluoroscopy requires repeated x-ray imaging during diagnosis and therapy. Patient exposure depends on procedure complexity, patient anatomy, fluoroscopy duration, equipment configuration, and operator technique. Clinical guidance indicates that therapeutic ERCP can involve substantially greater radiation exposure than shorter diagnostic examinations. This makes radiation reduction an important requirement when hospitals evaluate new systems.

Equipment acquisition costs also influence purchasing decisions. A modern fluoroscopy system requires an x-ray generator, tube, digital detector, imaging software, patient table, monitors, radiation shielding, networking infrastructure, and installation services. Dedicated ERCP suites can require additional integration with endoscopy equipment, anesthesia systems, contrast delivery, and procedure-room infrastructure.

Smaller hospitals may face difficulty justifying dedicated systems when ERCP procedure volumes are limited. Maintenance contracts, detector replacement, software upgrades, staff training, and regulatory compliance add to the total ownership burden. Hospitals must therefore balance clinical demand against capital expenditure and operational utilization. These considerations can extend replacement cycles and encourage some facilities to continue using older systems longer than manufacturers would prefer.

OPPORTUNITY

"Integration of artificial intelligence, low-dose imaging, and multifunctional fluoroscopy platforms."

Technology integration represents a significant opportunity for the medical x-ray fluoroscopy system for ERCP market. Artificial intelligence can improve workflow consistency by supporting image optimization, positioning, protocol selection, and automated system settings. Dose-management software can provide real-time feedback and help clinicians maintain radiation exposure at appropriate levels.

Multifunctional platforms are also becoming attractive because hospitals can use one system for fluoroscopy, radiography, gastrointestinal examinations, and selected interventional procedures. Siemens Healthineers developed the Luminos Q.namix platform to combine fluoroscopy and radiography with streamlined controls, predefined clinical protocols, workflow guidance, and low-dose imaging.

Flat-panel detectors provide another opportunity. Digital detectors can improve image quality, support large-area visualization, and simplify integration with hospital information systems. Improved image processing can also help maintain diagnostic visibility at lower exposure settings.

Emerging hospitals in Asia, the Middle East, Latin America, and other developing healthcare markets represent additional opportunities. As healthcare providers expand gastroenterology departments and establish advanced endoscopy centers, demand for dedicated fluoroscopy equipment is increasing. Suppliers that offer scalable systems, training, financing, remote service, and efficient installation can improve adoption in facilities with limited technical resources.

CHALLENGE

"Maintaining image quality while reducing radiation exposure during complex therapeutic procedures."

The primary technical challenge is achieving sufficient image quality without unnecessarily increasing radiation exposure. ERCP involves small anatomical structures, guidewires, contrast-filled ducts, and interventional devices that must remain visible throughout the procedure. Poor image quality can make device positioning difficult, while excessive radiation can increase risk for patients and healthcare professionals.

The complexity of therapeutic procedures makes this balance particularly difficult. Longer procedures, repeated contrast injections, difficult anatomy, and multiple device exchanges can increase fluoroscopy requirements. Equipment manufacturers therefore need advanced pulsed fluoroscopy, noise-reduction algorithms, detector sensitivity, dose monitoring, and optimized image processing.

Ergonomics is another challenge. Gastroenterologists, endoscopy nurses, radiologic technologists, and anesthesia teams often work around the patient simultaneously. Equipment must allow adequate access without obstructing endoscopic equipment or staff movement. Large systems can require significant procedure-room space.

Interoperability also presents challenges. Modern fluoroscopy systems must communicate with hospital networks, picture archiving systems, radiology information systems, and digital endoscopy platforms. Cybersecurity requirements are becoming more important as imaging systems become network-connected. Manufacturers must therefore deliver secure software, reliable connectivity, and long-term technical support while maintaining clinical usability.

Medical X-Ray Fluoroscopy System for ERCP Market Segmentation

By Type

Fixed X-ray Fluoroscopy System: Fixed x-ray fluoroscopy systems account for approximately 65% of the global medical x-ray fluoroscopy system for ERCP market, making them the dominant product category. These systems are permanently installed in dedicated imaging or endoscopy rooms and provide stable imaging geometry for complex gastrointestinal procedures.

Fixed systems are particularly suitable for high-volume hospitals because they can support repeated ERCP procedures throughout the day. Their larger detector configurations, adjustable patient tables, ceiling-mounted components, and integrated imaging controls provide clinicians with greater flexibility during complicated interventions. Dedicated systems can also integrate with endoscopy equipment and hospital digital infrastructure.

The category benefits from continuous improvements in flat-panel detector technology, automated positioning, pulsed fluoroscopy, image processing, and radiation monitoring. Modern systems increasingly incorporate touch displays and workflow assistance to reduce operator workload. Fixed platforms are especially valuable for therapeutic ERCP involving stone extraction, dilation, biopsy, and stent placement, where precise real-time visualization is essential.

Mobile X-ray Fluoroscopy System: Mobile x-ray fluoroscopy systems represent approximately 35% of the medical x-ray fluoroscopy system for ERCP market and provide flexibility that fixed installations cannot offer. These systems can be moved between procedure rooms and can support hospitals where dedicated fluoroscopy suites are not continuously occupied.

Mobile systems are attractive to smaller hospitals, outpatient facilities, and healthcare providers seeking to expand fluoroscopy access without constructing a permanent imaging room. They can also provide backup imaging capacity when fixed equipment is unavailable.

Technological improvements are making mobile systems increasingly capable. Digital flat-panel detectors, compact high-frequency generators, wireless communication, automated positioning, and improved image processing have expanded their clinical usefulness. Although mobile systems may not provide the same room integration and positioning flexibility as dedicated fixed platforms, their portability provides a significant operational advantage. The fastest development in the broader ERCP fluoroscopy equipment segment is associated with mobile systems, supported by demand for flexible imaging infrastructure.

By Application

Public Hospital: Public hospitals account for approximately 58% of the medical x-ray fluoroscopy system for ERCP market by application. These institutions generally serve large patient populations and often operate major gastroenterology, emergency, oncology, and surgical departments.

High patient volumes encourage public hospitals to invest in reliable fixed fluoroscopy systems capable of supporting repeated procedures. Equipment selection is frequently influenced by lifecycle cost, maintenance requirements, radiation performance, workflow efficiency, and compatibility with existing hospital infrastructure.

Public healthcare modernization programs also create opportunities for suppliers offering standardized systems across multiple facilities. Large hospital networks may purchase multiple units through centralized procurement programs, allowing manufacturers to establish long-term service relationships.

Public hospitals increasingly require digital connectivity because imaging data must be transferred to electronic medical records and hospital information systems. Suppliers that provide robust interoperability, cybersecurity, training, and preventive maintenance can strengthen their position in this segment.

Private Hospital: Private hospitals represent approximately 42% of the market by application and generally place strong emphasis on advanced technology, patient experience, operational efficiency, and premium procedural capabilities. High-end private hospitals are increasingly establishing dedicated gastrointestinal intervention centers with advanced fluoroscopy and endoscopy equipment.

Private healthcare providers can benefit from systems that shorten procedure preparation, simplify positioning, improve image quality, and support lower radiation exposure. Automated controls and intuitive interfaces can also reduce training requirements and improve room utilization.

Premium facilities may prioritize larger detectors, high-resolution imaging, advanced dose management, integrated digital storage, and specialized workflow software. Private hospitals are also more likely to invest in equipment that can support multiple gastrointestinal and interventional procedures, increasing utilization beyond ERCP alone. This makes multifunctional fluoroscopy systems attractive for facilities seeking higher equipment productivity and flexible procedure scheduling.

Medical X-Ray Fluoroscopy System for ERCP Market Regional Outlook

• North America

North America accounts for approximately 40% of the global medical x-ray fluoroscopy system for ERCP market, making it the leading regional market. The United States represents the largest national market within the region because of its extensive hospital infrastructure, established gastroenterology specialty, and high adoption of advanced medical imaging technologies.

The region benefits from strong demand for therapeutic ERCP, particularly in tertiary hospitals and specialized gastrointestinal centers. Healthcare providers increasingly prioritize systems that combine high-resolution digital imaging with radiation-dose monitoring and ergonomic operation.

Fixed fluoroscopy systems dominate major hospitals because dedicated ERCP suites require consistent imaging performance and integration with endoscopy systems. Mobile systems are also used in smaller hospitals and facilities requiring flexible imaging capacity.

Canada contributes to regional demand through public hospital modernization and investment in advanced diagnostic and interventional technologies. North American manufacturers and hospitals are also active in clinical research involving low-dose imaging, artificial intelligence, image enhancement, and advanced endoscopic procedures.

The region's established service infrastructure supports equipment replacement and software upgrades. Hospitals increasingly consider total ownership cost, cybersecurity, interoperability, and preventive maintenance when purchasing new systems. These factors sustain North America's leading position.

• Europe

Europe represents approximately 30% of the global medical x-ray fluoroscopy system for ERCP market and remains a major center for advanced gastroenterology and medical imaging. Germany, the United Kingdom, France, Italy, and Spain contribute significantly to regional demand.

European healthcare systems increasingly emphasize radiation protection, efficient hospital workflows, and minimally invasive treatment. This encourages demand for fluoroscopy systems incorporating pulsed imaging, dose monitoring, improved detector sensitivity, and automated workflow tools.

Germany is particularly important because of its strong medical technology sector and extensive network of university hospitals and specialized gastrointestinal centers. The United Kingdom benefits from centralized healthcare procurement and increasing adoption of digital imaging technologies.

European hospitals are also increasingly focused on equipment sustainability and energy efficiency. Manufacturers that provide longer product lifecycles, upgradeable software, recyclable components, and efficient service programs can improve competitiveness.

The region's aging population contributes to demand for gastrointestinal diagnostic and therapeutic procedures. Modern fluoroscopy platforms are therefore being integrated into specialized endoscopy units where clinicians require reliable imaging during complex ERCP interventions.

• Germany Medical X-Ray Fluoroscopy System for ERCP Market Insights

Germany represents approximately 32% of European medical x-ray fluoroscopy system for ERCP demand and is the leading national market in the region. The country's extensive hospital network, specialist gastroenterology services, and strong medical technology manufacturing base support equipment adoption.

German hospitals increasingly prioritize digital fluoroscopy systems with high image quality, dose management, ergonomic positioning, and efficient networking. Academic medical centers are particularly active in advanced therapeutic endoscopy and complex biliary interventions.

Germany also has strong local expertise in fluoroscopy equipment, engineering, medical imaging software, and radiation protection. Suppliers compete through technical performance, service coverage, customization, and integration capabilities.

The replacement of older fluoroscopy equipment creates an additional demand source as hospitals seek systems compatible with modern digital infrastructure. Energy efficiency and lifecycle management are also becoming more relevant in procurement decisions.

• United Kingdom Medical X-Ray Fluoroscopy System for ERCP Market Insights

The United Kingdom accounts for approximately 21% of European medical x-ray fluoroscopy system for ERCP demand. The market is supported by the country's established healthcare system, specialist gastrointestinal services, and continued investment in modern diagnostic imaging.

Public hospitals represent an important purchasing segment, with equipment procurement frequently emphasizing clinical effectiveness, safety, maintenance, and total ownership cost. Fixed fluoroscopy systems are widely used in major hospitals where ERCP procedure volumes justify dedicated imaging facilities.

The United Kingdom is also placing greater emphasis on radiation protection and workflow efficiency. Digital dose monitoring, pulsed fluoroscopy, and improved image processing are becoming increasingly relevant.

Private healthcare providers contribute additional demand for premium imaging systems, particularly in major metropolitan areas. Hospitals are also seeking equipment that can integrate with endoscopy systems and electronic patient records, supporting more efficient procedural documentation and data management.

• Asia

Asia represents approximately 20% of the global medical x-ray fluoroscopy system for ERCP market and offers substantial opportunities because of expanding healthcare infrastructure, increasing access to specialist gastroenterology, and growing medical technology investment. China represents the largest national market in the region, followed by Japan and India.

China's large hospital system and increasing adoption of advanced minimally invasive procedures are strengthening demand for digital fluoroscopy systems. Domestic manufacturers are expanding their product portfolios and competing with international suppliers through localized manufacturing and competitive pricing.

Japan has a mature medical imaging infrastructure and strong demand for precision fluoroscopy equipment. Hospitals emphasize reliability, compact design, dose management, and advanced imaging performance.

India is experiencing increasing investment in private hospitals, tertiary care centers, and specialist endoscopy facilities. This is creating opportunities for both fixed and mobile fluoroscopy systems.

South Korea and Southeast Asian markets are also developing through hospital modernization and expansion of advanced gastrointestinal services. Suppliers that provide affordable equipment, training, technical support, and flexible financing can benefit from the region's expanding healthcare capacity.

• Japan Medical X-Ray Fluoroscopy System for ERCP Market Insights

Japan represents approximately 24% of Asian medical x-ray fluoroscopy system for ERCP demand and remains an important market for high-quality medical imaging systems. Its mature healthcare infrastructure supports widespread access to advanced diagnostic and therapeutic procedures.

Japanese hospitals emphasize compact equipment, operational reliability, radiation management, and high-quality digital imaging. Local manufacturers have extensive expertise in x-ray generators, flat-panel detectors, image processing, and precision mechanical systems.

The country's aging population contributes to demand for gastrointestinal procedures and chronic disease management. Hospitals are increasingly upgrading older fluoroscopy platforms with digital detectors and improved dose-management functions.

Japan's strong medical technology industry also supports continuous product development. Manufacturers are integrating automation, touch controls, advanced image processing, and network connectivity to improve procedure-room efficiency.

• China Medical X-Ray Fluoroscopy System for ERCP Market Insights

China represents approximately 39% of Asian medical x-ray fluoroscopy system for ERCP demand and is the largest national market in Asia. The country's extensive hospital network and increasing investment in advanced gastrointestinal services are major demand drivers.

Public hospitals account for a significant proportion of equipment procurement because they serve large patient populations and increasingly expand minimally invasive treatment capabilities. Private hospitals are also investing in advanced fluoroscopy systems to differentiate their specialist services.

Domestic manufacturers such as Wandong Medical and Shinva Medical are competing alongside international suppliers. Local production can provide advantages in pricing, customization, distribution, and after-sales service.

China is also expanding digital healthcare infrastructure, increasing the importance of network connectivity, image storage, cybersecurity, and interoperability. Advanced fixed fluoroscopy systems remain important in tertiary hospitals, while mobile systems provide opportunities for smaller facilities and flexible procedure environments.

• Middle East & Africa

Middle East and Africa account for approximately 10% of the global medical x-ray fluoroscopy system for ERCP market. Demand is concentrated in countries with advanced private healthcare systems, major tertiary hospitals, medical tourism infrastructure, and government-supported healthcare modernization.

Saudi Arabia, the United Arab Emirates, South Africa, Turkey, and other regional markets are investing in modern diagnostic and interventional equipment. Premium hospitals increasingly offer advanced gastrointestinal procedures, creating demand for reliable fluoroscopy systems.

Private healthcare groups are important buyers because they often prioritize high-end imaging, rapid workflow, patient comfort, and advanced procedural capabilities. Public hospitals are also upgrading equipment as governments expand specialized healthcare services.

The region's developing gastroenterology infrastructure creates opportunities for both fixed and mobile systems. Mobile systems can be particularly useful where healthcare providers need flexible imaging capacity across multiple procedure rooms.

Training and technical support remain important purchasing considerations. Suppliers that provide installation, operator education, preventive maintenance, and remote technical support can strengthen their regional market presence.

Key Industry Players

The medical x-ray fluoroscopy system for ERCP market includes global imaging manufacturers, established fluoroscopy specialists, regional medical equipment producers, and emerging technology companies. Siemens Healthineers, Shimadzu, Canon, Philips, and GE Healthcare compete through advanced imaging, dose reduction, digital workflow, and integrated hospital solutions. Fujifilm combines imaging expertise with endoscopy technologies, creating opportunities for integrated gastrointestinal solutions. Chinese suppliers such as Wandong Medical and Shinva Medical compete through localized production and cost-efficient systems. European companies including General Medical Merate and Italray emphasize specialized fluoroscopy platforms. Competitive strategies increasingly involve artificial intelligence, flat-panel detectors, automated positioning, lower-dose imaging, cybersecurity, workflow integration, service networks, and strategic hospital partnerships.

List Of Top Medical X-Ray Fluoroscopy System For ERCP Companies

• Siemens Healthineers GmbH
• Shimadzu
• Canon
• Philips
• GE Healthcare
• Fujifilm Holdings Corporation
• Wandong Medical
• General Medical Merate (GMM)
• Shenzhen Angell Technology
• UMG/DEL MEDICAL
• Shinva Medical
• Allengers Medical Systems
• Nanjing Perlove Medical
• Italray
• Browiner
• Xingaoyi MEDICAL

List Of Top Two  Companies Market Share

• Siemens Healthineers GmbH: Siemens leads competitive positioning through advanced fixed fluoroscopy platforms and integrated low-dose imaging technologies.
• GE Healthcare: GE Healthcare maintains strong positioning through digital fluoroscopy, advanced imaging software, and broad global hospital relationships.

Investment Analysis And Opportunities

Investment opportunities in the medical x-ray fluoroscopy system for ERCP market are concentrated in digital detector technology, low-dose imaging, artificial intelligence, automated positioning, and multifunctional fluoroscopy platforms. Approximately 65% of the market is associated with fixed systems, demonstrating the continuing importance of dedicated procedure-room infrastructure.

Investment in mobile fluoroscopy is also attractive because flexible imaging systems can expand access in hospitals where dedicated rooms are unavailable. Asia presents substantial opportunities because healthcare infrastructure is expanding and specialist gastrointestinal services are becoming more accessible. Private hospitals in emerging markets are increasingly investing in premium imaging systems to strengthen their gastroenterology offerings. Companies that combine imaging hardware with software, service, training, and endoscopy integration can create stronger long-term commercial relationships.

New Product Development

New product development is focused on high-resolution flat-panel detectors, artificial intelligence, automated positioning, dose reduction, intuitive controls, and multifunctional imaging platforms. Siemens Healthineers' Luminos Q.namix platforms combine fluoroscopy and radiography with workflow guidance, touch interfaces, predefined clinical protocols, and low-dose imaging.

Shimadzu expanded its mobile fluoroscopy portfolio in April 2026 with the SC15 and OPESCOPE ACTENO FD15. The system includes a 12-inch flat-panel detector, a 15 kW high-voltage generator, a 43-inch monitor, virtual collimation, and image-processing capabilities. Canon's Adora DRFi also demonstrates the movement toward hybrid imaging, combining radiography and fluoroscopy with automated positioning and a wireless detector. These developments show that manufacturers are moving beyond basic fluoroscopy toward integrated systems designed to improve image quality, workflow efficiency, positioning, and radiation management.

Medical X-Ray Fluoroscopy System For ERCP Five Recent Developments (2025–2026)

• July 2025 — Siemens Healthineers: Siemens receives U.S. clearance for next-generation fluoroscopy and radiography platforms supporting streamlined low-dose clinical workflows.

Siemens Healthineers received FDA clearance for Luminos Q.namix R and T, combining fluoroscopy, radiography, AI-assisted workflow guidance, intuitive controls, and dose optimization.

• March 2025 — Canon: Canon launches Adora DRFi in the United States as an automated hybrid radiography and fluoroscopy imaging platform.

Canon Medical introduced Adora DRFi, combining radiography and low-dose fluoroscopy, automated positioning, wireless detection, flexible patient access, and improved procedural efficiency.

• April 2026 — Shimadzu: Shimadzu expands mobile fluoroscopy portfolio with new high-definition C-arm systems for flexible clinical imaging.

Shimadzu launched SC15 and OPESCOPE ACTENO FD15, integrating flat-panel detection, high-definition imaging, virtual collimation, a 43-inch monitor, and versatile positioning.

• May 2025 — GE Healthcare: GE Healthcare advances artificial intelligence capabilities for improved image-guided procedures and interventional imaging workflows.

GE Healthcare launched CleaRecon DL, applying deep-learning reconstruction to improve cone-beam computed tomography image quality and reduce artifacts during interventional procedures.

• October 2025 — Philips: Philips reaches major Zenition installation milestone, strengthening access to mobile fluoroscopy and image-guided intervention technologies globally.

Philips announced its 5,000th Zenition mobile C-arm installation, supporting surgical and interventional imaging across more than 170 countries with advanced workflow capabilities.

Medical X-Ray Fluoroscopy System For ERCP Market Report Coverage

The medical x-ray fluoroscopy system for ERCP market report covers product types, hospital applications, regional performance, competitive positioning, technology development, investment opportunities, and industry challenges. Type analysis includes fixed x-ray fluoroscopy systems and mobile x-ray fluoroscopy systems, while application analysis covers public hospitals and private hospitals. Regional assessment includes North America, Europe, Asia, and Middle East and Africa, with detailed country insights for the United States, Germany, the United Kingdom, Japan, and China. Competitive coverage evaluates 16 major companies, including Siemens Healthineers, Shimadzu, Canon, Philips, GE Healthcare, Fujifilm, Wandong Medical, General Medical Merate, and other regional manufacturers. The report also examines digital detectors, dose management, artificial intelligence, automated workflows, equipment modernization, and recent product developments.